S |
2020-05-26 21:11:32.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
LYTTON LAURENCE W |
4.99% |
view |
B |
2020-02-14 13:30:47.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
Nantahala Capital Management |
8.6% |
view |
B |
2020-02-13 17:56:48.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
Stonepine Capital Management |
9.99% |
view |
S |
2020-02-04 10:35:36.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
Samjo Capital LLC |
4.642% |
view |
B |
2019-09-27 18:19:22.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
LYTTON LAURENCE W |
5.2% |
view |
B |
2019-02-14 14:09:11.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
PRICE T ROWE ASSOCIATES INC |
7.0% |
view |
S |
2019-02-13 16:16:49.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
GLAXOSMITHKLINE PLC |
3.0% |
view |
B |
2018-02-12 10:01:45.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
PUTNAM INVESTMENTS LLC |
12.0% |
view |
B |
2018-01-22 16:38:19.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
QIAGEN NV |
13.1% |
view |
S |
2017-08-31 17:36:12.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
Novo Holdings A |
0.43% |
view |
S |
2017-08-23 09:07:03.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
GLAXOSMITHKLINE PLC |
8.3% |
view |
S |
2017-07-19 18:30:32.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
Novo Holdings A |
15.9% |
view |
S |
2017-03-29 16:05:37.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
GLAXOSMITHKLINE PLC |
18.1% |
view |
B |
2017-02-14 15:06:17.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
PUTNAM INVESTMENTS LLC |
10.6% |
view |
B |
2016-11-09 15:32:42.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
PUTNAM INVESTMENTS LLC |
8.4% |
view |
B |
2016-02-12 09:11:37.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
BlackRock Inc |
10.4% |
view |
B |
2015-06-10 10:30:02.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
Merck Capital Ventures LLC |
11.6% |
view |
B |
2015-05-15 15:04:54.0 |
HTG MOLECULAR DIAGNOSTICS |
HTGM |
Novo A |
19.0% |
view |